Clinical Trials Browser

Phase 2 × INDUSTRY × rozanolixizumab × Clear all

NCT03052751 2021-08-03

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Phase 2 Completed

43 enrolled 12 charts

Myasthenia Gravis